PH18083A - Pyridyl alkyl nitrate compound,process for preparation thereof and pharmaceutical composition comprising the same - Google Patents
Pyridyl alkyl nitrate compound,process for preparation thereof and pharmaceutical composition comprising the sameInfo
- Publication number
- PH18083A PH18083A PH29255A PH29255A PH18083A PH 18083 A PH18083 A PH 18083A PH 29255 A PH29255 A PH 29255A PH 29255 A PH29255 A PH 29255A PH 18083 A PH18083 A PH 18083A
- Authority
- PH
- Philippines
- Prior art keywords
- preparation
- pharmaceutical composition
- same
- nitrate compound
- alkyl nitrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8221592 | 1982-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH18083A true PH18083A (en) | 1985-03-18 |
Family
ID=10531922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH29255A PH18083A (en) | 1982-07-26 | 1983-07-20 | Pyridyl alkyl nitrate compound,process for preparation thereof and pharmaceutical composition comprising the same |
Country Status (17)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
| US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 FI FI832490A patent/FI832490L/fi not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES524375A0/es active Granted
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko active IP Right Grant
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5951263A (ja) | 1984-03-24 |
| EP0100081A3 (en) | 1985-05-02 |
| CA1216850A (en) | 1987-01-20 |
| DK311683A (da) | 1984-01-27 |
| ZA835048B (en) | 1984-03-28 |
| SU1189337A3 (ru) | 1985-10-30 |
| HU190497B (en) | 1986-09-29 |
| ATE40948T1 (de) | 1989-03-15 |
| US4613608A (en) | 1986-09-23 |
| EP0100081A2 (en) | 1984-02-08 |
| JPS6350343B2 (US06291489-20010918-C00077.png) | 1988-10-07 |
| FI832490L (fi) | 1984-01-27 |
| EP0100081B1 (en) | 1989-03-01 |
| NO832700L (no) | 1984-02-06 |
| FI832490A0 (fi) | 1983-07-07 |
| ES8502088A1 (es) | 1984-12-16 |
| KR840005426A (ko) | 1984-11-12 |
| GR78629B (US06291489-20010918-C00077.png) | 1984-09-27 |
| US4540701A (en) | 1985-09-10 |
| AU1663583A (en) | 1984-02-02 |
| DK311683D0 (da) | 1983-07-05 |
| DE3379255D1 (en) | 1989-04-06 |
| ES524375A0 (es) | 1984-12-16 |
| AU565791B2 (en) | 1987-10-01 |
| KR900005470B1 (ko) | 1990-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT37128A (en) | Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent | |
| MY101891A (en) | Novel carbostyril derivative and process for preparing same. | |
| DE3279103D1 (en) | New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them | |
| ES8706664A1 (es) | Procedimiento para preparar compuestos carbostirilicos | |
| ES8306160A1 (es) | "procedimiento para preparar un nuevo compuesto de cefem". | |
| ES8505690A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem. | |
| HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
| ES8307824A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem. | |
| GR3001506T3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
| ES8404360A1 (es) | Un procedimiento para preparar compuestos de cefem. | |
| PH24176A (en) | New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same | |
| DE3379255D1 (en) | Pyridyl alkyl nitrate compound, process for preparation thereof and pharmaceutical composition comprising the same | |
| GR3003126T3 (en) | Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments | |
| ES8201531A1 (es) | Procedimiento de preparar alcoxi propanolaminas | |
| IL91756A0 (en) | Pyridoindole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ES8502094A1 (es) | Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina. | |
| ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ES8302719A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| ES8504820A1 (es) | Un procedimiento para preparar compuestos de cefem que tienen grupos tiadiazol c isotiazol. | |
| PH22441A (en) | Quinate salts of the antimaterial compound mefloquine | |
| GB1000781A (en) | ª-morpholinobutyrophenone and its salts |